Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Julphar
Covington
Federal Trade Commission
Cipla
Moodys
US Department of Justice
Express Scripts
Teva

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021627

« Back to Dashboard

NDA 021627 describes NAMENDA, which is a drug marketed by Allergan Sales Llc and Forest Labs Llc and is included in three NDAs. It is available from eight suppliers. There are seven patents protecting this drug and five Paragraph IV challenges. Additional details are available on the NAMENDA profile page.

The generic ingredient in NAMENDA is memantine hydrochloride. There are twenty-eight drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the memantine hydrochloride profile page.
Summary for 021627
Tradename:NAMENDA
Applicant:Allergan Sales Llc
Ingredient:memantine hydrochloride
Patents:0
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021627

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;ORALStrength2MG/ML
Approval Date:Apr 18, 2005TE:RLD:Yes

Expired US Patents for NDA 021627

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc NAMENDA memantine hydrochloride SOLUTION;ORAL 021627-001 Apr 18, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Sales Llc NAMENDA memantine hydrochloride SOLUTION;ORAL 021627-001 Apr 18, 2005 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
Healthtrust
Johnson and Johnson
Colorcon
Argus Health
Dow
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.